INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹137 Cr | ₹99 Cr | ₹236 Cr | ₹286 Cr | ₹326 Cr |
What is the latest Operating Profit of INDOCO REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹137 Cr |
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹286 Cr |
| Mar2022 | ₹326 Cr |
How is Operating Profit of INDOCO REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹137 Cr | 38.22 | |
| Mar2025 | ₹99 Cr | -58.02 | |
| Mar2024 | ₹236 Cr | -17.35 | |
| Mar2023 | ₹286 Cr | -12.32 | |
| Mar2022 | ₹326 Cr | - | |
Compare Operating Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,098.0 Cr | -7.4% | -10.6% | -22.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -7.4% |
-10.6% |
-22.9% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses